| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 6 |
| 1 | METHOTREXATE SODIUM | 5 |
| 2 | BEVACIZUMAB | 4 |
| 3 | LOMUSTINE | 4 |
| 4 | METHOTREXATE | 4 |
| 5 | PROCARBAZINE HYDROCHLORIDE | 4 |
| 6 | TEMOZOLOMIDE | 4 |
| 7 | ETANERCEPT | 3 |
| 8 | GOLIMUMAB | 3 |
| 9 | IXEKIZUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LOMUSTINE | 4 | 0.0015 |
| 1 | PROCARBAZINE HYDROCHLORIDE | 4 | 0.0008 |
| 2 | ACARBOSE | 1 | 0.0003 |
| 3 | GOLIMUMAB | 3 | 0.0002 |
| 4 | TEMOZOLOMIDE | 4 | 0.0002 |
| 5 | ROFLUMILAST | 1 | 0.0001 |
| 6 | POSACONAZOLE | 2 | 0.0001 |
| 7 | LIOTHYRONINE SODIUM | 1 | 0.0001 |
| 8 | HYDROXYUREA | 2 | 0.0001 |
| 9 | FREMANEZUMAB-VFRM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 2 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 4 | 0.0000 |